Search clinical trials for: Fluorescent in-situ hybridization (FISH)

Total 212 results

Assiut University
South Egypt Cancer Institute

Completed

Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AML

Acute Myeloid Leukemia

Egypt
Istituto Clinico Humanitas

Unknown

Level of HER2-neu Gene Amplification an Response to Trastuzumab

Advanced Breast Cancer

Italy
Krankenhaus Barmherzige Schwestern Linz
Verein zur Forschungsförderung der Krebshilfe OÖ; RECENDT GmbH; Johannes Kepler... and other collaborators

Recruiting

Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer (ROOCT)

Head and Neck Cancer | Radiotherapy

Austria
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Lymphoma | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant Condition
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Brain Tumors | Central Nervous System Tumors

United States, Australia, Canada
Institut Curie

Completed

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Breast Cancer

France
Mahdis Bayat

Completed

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

HER2 Low Breast Carcinoma
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Melanoma (Skin)

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Myelodysplastic Syndromes | Leukemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Spectroscopy of Breast Tissue

Breast Cancer

United States
Roswell Park Cancer Institute

Withdrawn

Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
Grupo Español de Tratamiento de Tumores de Cabeza...

Active, not recruiting

Spanish Study for Molecular Characterization of Thyroid Carcinoma (MOLTHY)

Differentiated Thyroid Carcinoma | Medullary Thyroid Carcinoma

Spain
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Leukemia
University of Southern California
National Cancer Institute (NCI); GlaxoSmithKline

Terminated

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Recurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Myelodysplastic Syndromes | Anemia | Prostate Cancer | Metastatic Cancer | Precancerous Condition

United States
Bayer

Completed

A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease (CADA DIA)

Diabetic Kidney Disease

Spain, Denmark, Bulgaria, Israel, Sweden, Finland, Italy
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Breast Cancer
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Study of Ductal Lavage in Women at High Risk for Breast Cancer

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Leukemia

United States
Leeds Cancer Centre at St. James's University Hospital

Completed

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Leukemia

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers

Sarcoma
Mayo Clinic

Completed

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditions

United States
Assiut University

Not yet recruiting

Immunophenotyping and Xist Gene in AML (Xist)

Acute Myeloid Leukemia

Egypt
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Unknown

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

Neuroblastoma
European Organisation for Research and Treatment...

Completed

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

Brain and Central Nervous System Tumors

Switzerland
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (PIMABI)

Colorectal Cancer

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Head and Neck Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors

Kidney Cancer
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Testicular Germ Cell Tumor | Pancreatic Cancer | Small Intestine Cancer | Non-melanomatous Skin Cancer

United States
The Second Affiliated Hospital of Dalian Medical...
Fudan University; West China Hospital; Shengjing Hospital; The First Affiliated... and other collaborators

Recruiting

Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

Lung Cancer

China
Rigshospitalet, Denmark
Copenhagen Trial Unit, Center for Clinical Intervention Research

Completed

'In Situ Simulation' Versus 'Off Site Simulation' in Obstetric Emergencies

Simulation | Education | Obstetrics | 'In Situ Simulation'

Denmark
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Lung Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Patients With Rhabdomyosarcoma

Sarcoma
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

Lung Cancer
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (IRB 2000-294)

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Liver Cancer
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Intraocular Melanoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

Head and Neck Cancer
City of Hope Medical Center
OSI Pharmaceuticals

Completed

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Completed

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Stage III Colon Cancer | Stage III Rectal Cancer | Adenocarcinoma of the Colon

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Cancer

United States
Fred Hutchinson Cancer Research Center/University...

Withdrawn

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
Children's Cancer and Leukaemia Group

Unknown

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Brain and Central Nervous System Tumors

France, United Kingdom, Ireland

Search clinical trials for: Fluorescent in-situ hybridization (FISH)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations